Prognostic significance of biochemical markers in African Burkitt's lymphoma

Clinical and Translational Oncology

Volumn 13, Issue 10, 2011, Pages 731-736

  Arthur, Fareed Kow Nanse ^a   Owusu, Lawrence ^a   Yeboah, Francis Agyemang ^a,b   Rettig, Theresa ^b   Osei Akoto, Alex ^b  

^a KWAME NKRUMAH UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Ghana)

^b KOMFO ANOKYE TEACHING HOSPITAL   (Ghana)

Author keywords

African endemic Burkitt's lymphoma; Biochemical markers; Prognostic indices; Survival analysis

Indexed keywords

ALLOPURINOL; BIOLOGICAL MARKER; CYCLOPHOSPHAMIDE; DOXORUBICIN; LACTATE DEHYDROGENASE; METHOTREXATE; PREDNISOLONE; VINCRISTINE;

ADOLESCENT; ARTICLE; BURKITT LYMPHOMA; CANCER SURVIVAL; CHILD; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DISEASE MARKER; DRUG FATALITY; FEMALE; FOLLOW UP; HUMAN; INFANT; LACTATE DEHYDROGENASE BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PREDICTION; PRESCHOOL CHILD; PROGNOSIS; PROGRESSION FREE SURVIVAL; RETROSPECTIVE STUDY; SEX DIFFERENCE; SEX RATIO;

ADOLESCENT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BIOLOGICAL MARKERS; BURKITT LYMPHOMA; CHILD; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; CYCLOPHOSPHAMIDE; DOXORUBICIN; FEMALE; GHANA; HUMANS; INFANT; MALE; METHOTREXATE; PREDNISOLONE; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE; VINCRISTINE;

EID: 81255201491     PISSN: 1699048X     EISSN: 16993055     Source Type: Journal    
DOI: 10.1007/s12094-011-0724-8     Document Type: Article

References (23)

1. I. Magrath 1990 The pathogenesis of Burkitt's lymphoma Adv Cancer Res 55 133 270 2166998 10.1016/S0065-230X(08)60470-4 1:STN:280:DyaK3czltVGkug%3D%3D (Pubitemid 20259302)
2. M. Ansari M. Krajinovic 2007 Pharmacogenomics in cancer treatment defining the genetic bases for inter-individual differences in response to chemotherapy Curr Opin Pediatr 19 15 22 17224657 10.1097/MOP.0b013e3280140613 (Pubitemid 46114753)
3. M.A. Shipp 1993 for The International Non-Hodgkin's Lymphoma Prognostic Factors Project: a predictive model for aggressive Non-Hodgkin's Lymphoma: The International Non-Hodgkin's Lymphoma Project N Engl J Med 329 987 994 10.1056/NEJM199309303291402 (Pubitemid 23307906)
4. J. Hermans A.D.G. Krol K. van Groningen, et al. 1995 International Prognostic Index is valid for all malignant grades Blood 88 1460 1463
5. M. Federico V. Umberto P.L. Zinzani, et al. 2000 Prognosis of follicular lymphoma: a predictive model based on a retrospective analysis of 987 cases Blood 95 783 789 10648386 1:CAS:528:DC%2BD3cXotV2isg%3D%3D (Pubitemid 30062696)
6. C. Nicolaides G. Fountzilas N. Zoumbos, et al. 1998 Diffuse large cell lymphomas: identification of prognostic factors and validation of the international Non-Hodgkin's Lymphoma Prognostic Index Oncology 55 405 415 9732217 10.1159/000011886 1:STN:280:DyaK1cvgt1Gktw%3D%3D (Pubitemid 28396051)
7. C. Nocolaides S. Dimon N. Pavlidis 1998 Prognostic factors in aggressive non-Hodgkin's lymphomas Oncologist 3 189 197 (Pubitemid 28307450)
8. F. Plancarte A. López-Guillermo L. Arenillas, et al. 2006 Follicular lymphoma in early stages: high risk of relapse and usefulness of the Follicular Lymphoma International Prognostic Index to predict the outcome of patients Eur J Haematol 76 58 63 16343272 10.1111/j.1600-0609.2005.00564.x
9. M.F. Pedrosa F. Pedrosa M.M. Lins, et al. 2007 Non-Hodgkin's lymphoma in childhood: clinical and epidemiological characteristics and survival analysis at a single centre in Northeast Brazil J Pediatr (Rio J) 83 547 554 10.2223/JPED.1726 (Pubitemid 350261394)
10. L. Owusu F.A. Yeboah A. Sei-Akoto, et al. 2010 Clinical and epidemiological characterisation of Burkitt's lymphoma: an eight-year case study at Komfo Anokye Teaching Hospital, Ghana Br J Biomed Sci 67 9 14 20373676 1:STN:280:DC%2BC3c3ksFKlsA%3D%3D
11. B.D. Cheson S.J. Horning B. Coiffier, et al. 1999 Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas J Clin Oncol 17 1244 1253 10561185 1:STN:280:DC%2BD3c%2FivF2itg%3D%3D (Pubitemid 29162950)
12. J.M. Bland D.G. Altman 2004 The logrank test BMJ 328 1073 15117797 10.1136/bmj.328.7447.1073
13. F. Cabanilla J.S. Burke T.L. Smith, et al. 1978 Factors predicting response and survival in adults with advanced non-Hodgkin's lymphoma Arch Intern Med 138 413 418 10.1001/archinte.138.3.413 (Pubitemid 9059965)
14. R.J. Schneider K. Scibert S. Passe, et al. 1980 Prognostic significance of serum lactate dehydrogenase in malignant lymphomas Cancer 46 139 143 6992974 10.1002/1097-0142(19800701)46:1<139::AID-CNCR2820460122>3.0.CO;2-8 1:STN:280:DyaL3c3it1CksQ%3D%3D (Pubitemid 10080449)
15. R.I. Fisher S.M. Hubbard V.T. De Vita, et al. 1981 Factors predicting long-term survival in diffuse mixed, histiocytic or undifferentiated lymphoma Blood 58 45 51 7236892 1:STN:280:DyaL3M3gvVKltA%3D%3D (Pubitemid 11064459)
16. B. Coiffier C. Gisselbrecht J.M. Vose, et al. 1991 Prognostic factors in aggressive malignant lymphomas: description and validation of a prognostic index that could identify patients requiring a more intensive therapy The Groupe d'Etudes des Lymphomas Aggresifs. J Clin Oncol 9 211 219 1:STN:280: DyaK3M7gvVCqtA%3D%3D
17. P.J. Hoskin V. Ng J.J. Spinelli, et al. 1991 Prognostic variables in patients with diffuse large cell lymphoma treated with MACOP-B J Clin Oncol 9 220 226
18. R.C. Leonard R.L. Hayward R.J. Prescott, et al. 1991 The identification of discrete prognosis groups in low-grade non-Hodgkin's lymphoma Ann Oncol 2 655 662 1742221 1:STN:280:DyaK38%2FnsFGrtw%3D%3D
19. A. Lopez-Guillermo E. Montserrat F. Bosch, et al. 1994 Applicability of the International Index for aggressive lymphomas to patients with low-grade lymphoma J Clin Oncol 12 1343 1348 8021724 1:STN:280:DyaK2c3ptlSmuw%3D%3D
20. L. Pan P.C.L. Beverly P.G. Isaacson 1991 Lactate dehydrogenase (LDH) isoenzymes and proliferative activity of lymphoid cells: an immunocytochemical study Clin Exp Immunol 86 240 245 1934592 10.1111/j.1365-2249.1991.tb05803.x 1:CAS:528:DyaK38XlslamtA%3D%3D
21. Gaw A, Cowan RA, O'Reilly DStJ et al (1999) Clinical biochemistry, 2nd ed. Harcourt Brace and Company, Edinburgh, pp 12-44, 64-72
22. W.S. Velasquez L.M. Fuller S. Jaganuath, et al. 1991 Stage I and II diffuse large cell lymphoma: prognostic factors and long-term results with CHOP-bleo and radiation Blood 77 942 947 1704805 1:STN:280:DyaK3M7jslyhsw%3D%3D
23. D.O. Dixon B. Neilan S.E. Jones, et al. 1986 Effect of age on the therapeutic outcome in advanced diffused histiocytic lymphoma The Southwest Oncology Group Experience. J Clin Oncol 4 295 305 1:STN:280:DyaL287kt1yqtw%3D%3D (Pubitemid 16133082)